Madrigal Pharmaceuticals Share Price (NASDAQ: MDGL)

$407.75

▲

16.09

(4.11%)

Live

Last updated on August 22, 2025 at 12:36 AM IST

$₹

Check the interactive Madrigal Pharmaceuticals Stock chart to analyse performance

Madrigal Pharmaceuticals stock performance

as on August 22, 2025 at 12:36 AM IST

Today's Low:$393.61
Today's High:$411.22
$407.75
3.47%
Downside
Day's Volatility :4.28%
Upside
0.84%
52 Weeks Low:$200.63
52 Weeks High:$407.75
$407.75
50.8%
Downside
52 Weeks Volatility :50.8%
Upside
0.0%

Madrigal Pharmaceuticals Stock Returns

Period	Madrigal Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	43.62%	4.5%	0.0%
6 Months	11.84%	-6.1%	0.0%
1 Year	53.25%	-11.1%	0.0%
3 Years	459.17%	3.4%	-9.6%

Madrigal Pharmaceuticals, Inc. Key Stats

Check Madrigal Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$391.66
Open	$379.27
Today's High	$411.22
Today's Low	$393.61
Market Capitalization	$8.5B
Today's Volume	$312.7K
52 Week High	$411.22
52 Week Low	$200.63
Revenue TTM	$515.5M
EBITDA	$-308.4M
Earnings Per Share (EPS)	$-12.64
Profit Margin	-54.68%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-36.3%

Stock Returns calculator for Madrigal Pharmaceuticals Stock including INR - Dollar returns

The Madrigal Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Madrigal Pharmaceuticals investment value today

Current value as on today

₹1,63,099

Returns

₹63,099

(+63.1%)

Returns from Madrigal Pharmaceuticals Stock

₹59,172 (+59.17%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Madrigal Pharmaceuticals Stock

46%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Madrigal Pharmaceuticals Stock from India on INDmoney has increased by 46% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Madrigal Pharmaceuticals, Inc.

Name
Holdings %
Name
Holdings %
HHG PLC
9.86%
Paulson & Company Inc
9.40%
RTW INVESTMENTS, LLC
8.97%
Baker Bros Advisors LP
8.89%
Vanguard Group Inc
8.45%
venBio Select Advisor LLC
8.44%

Analyst Recommendation on Madrigal Pharmaceuticals Stock

Rating

Trend

Buy

80%Buy

14%Hold

4%Sell

Based on 21 Wall street analysts offering stock ratings for Madrigal Pharmaceuticals(by analysts ranked 0 to 5 stars)

Madrigal Pharmaceuticals Share Price Target

What analysts predicted

Upside of 10.29%

Target:

$449.71

Current:

$407.75

Madrigal Pharmaceuticals share price target is $449.71, a slight Upside of 10.29% compared to current price of $407.75 as per analysts' prediction.

Madrigal Pharmaceuticals Stock Insights

Price Movement
In the last 7 days, MDGL stock has moved up by 5.7%
MDGL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 10.8%
Price to Sales
ForMDGL every $1 of sales, investors are willing to pay $16.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Madrigal Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Madrigal Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Madrigal Pharmaceuticals, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Madrigal Pharmaceuticals, Inc.	25.27%	11.84%	53.25%	459.17%	279.64%
Regeneron Pharmaceuticals, Inc.	5.39%	-15.07%	-50.13%	-3.42%	-0.61%
Beone Medicines Ltd	4.61%	26.63%	56.19%	78.75%	30.26%
Vertex Pharmaceuticals Incorporated	-16.11%	-17.89%	-18.87%	34.22%	47.47%
Alnylam Pharmaceuticals, Inc.	40.82%	82.49%	64.08%	110.21%	247.67%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Madrigal Pharmaceuticals, Inc.	NA	NA	0.0	-8.98	-0.36	-0.18	NA	31.32
Regeneron Pharmaceuticals, Inc.	14.47	14.47	1.18	39.36	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.33	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.73	27.73	0.58	18.04	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Madrigal Pharmaceuticals, Inc.	Buy	$8.5B	279.64%	NA	-54.68%
Regeneron Pharmaceuticals, Inc.	Buy	$60.8B	-0.61%	14.47	31.37%
Beone Medicines Ltd	NA	$38.5B	30.26%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.0B	47.47%	27.73	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$60.1B	247.67%	NA	-12.96%

Madrigal Pharmaceuticals Dividend announcements

Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals’s price-to-earnings ratio stands at None

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Organization	Madrigal Pharmaceuticals
Employees	528
CEO	Mr. William J. Sibold
Industry	Health Technology

Key Management of Madrigal Pharmaceuticals, Inc.

Name	Title
Mr. William J. Sibold	CEO, President & Director
Dr. Rebecca A. Taub M.D.	Founder, Senior Scientific & Medical Advisor and Director
Ms. Mardi C. Dier	Executive VP & CFO
Ms. Shannon Kelley	Executive VP, Chief Legal Officer & Corporate Secretary
Ms. Carole Huntsman	Executive VP & Chief Commercial Officer
Mr. Mark Underwood	Executive Vice President of Business Planning & Operations
Mr. Ronald Filippo	Executive VP & Chief Information Officer
Ms. Tina E. Ventura	Chief Investor Relations Officer
Mr. Clint Wallace	Executive VP & Chief Human Resources Officer
Mr. Edward Chiang	Senior Vice President of Clinical & Technical Operations

Important FAQs about investing in MDGL Stock from India :

What is Madrigal Pharmaceuticals share price today?

Madrigal Pharmaceuticals share price today is $407.75 as on August 22, 2025 at 12:36 AM IST. Madrigal Pharmaceuticals share today touched a day high of $411.22 and a low of $393.61.

What is the 52 week high and 52 week low for Madrigal Pharmaceuticals share?

Madrigal Pharmaceuticals share touched a 52 week high of $407.75 and a 52 week low of $200.63. Madrigal Pharmaceuticals stock price today i.e. August 22, 2025 at 12:36 AM IST is trending at $407.75, lower by 0% versus the 52 week high.

How to invest in Madrigal Pharmaceuticals Stock (MDGL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Madrigal Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Madrigal Pharmaceuticals Shares that will get you 0.0037 shares as per Madrigal Pharmaceuticals share price of $407.75 per share as on August 22, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Madrigal Pharmaceuticals Stock (MDGL) from India?

Indian investors can start investing in Madrigal Pharmaceuticals (MDGL) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Madrigal Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Madrigal Pharmaceuticals share’s latest price of $407.75 as on August 22, 2025 at 12:36 AM IST, you will get 0.0245 shares of Madrigal Pharmaceuticals. Learn more about fractional shares .

What are the returns that Madrigal Pharmaceuticals has given to Indian investors in the last 5 years?

Madrigal Pharmaceuticals stock has given 279.64% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?